August 25, 2025 · Form 4 insider transaction
STAHLBERG JAN bought 338,265 shares of DIAMEDICA THERAPEUTICS INC at $6.00 per share, a transaction worth $2.03M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 10 days after the transaction.
These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares.